Operations

Targovax Granted EU Patent for Mutant-RAS Neoantigen Platform 2nd Generation Product TG02

June 19, 2018

OSLO, Norway, June 19, 2018 /PRNewswire/ — Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), is a clinical stage company focused on developing and commercializing immune activators to target hard to treat solid tumors, announces that the European Patent Office has granted European Patent no 3079715, A Peptide mixture. The patent protects the composition of […]

AcuraStem Receives Fast-Track SBIR Grant for the Development of a Novel Small Molecule Therapy to Treat ALS

June 19, 2018

MONROVIA, Calif.–(BUSINESS WIRE)–AcuraStem a fast-growing, innovative biotech company in Monrovia, California, has been awarded a 3.7 million dollar Small Business Innovation Research (SBIR) Fast-Track grant (#R44NS105156) by the National Institute of Neurological Disorders and Stroke (NINDS) to continue research for the development of a small molecule therapeutic, “AS2015”, focused on treating patients with the genetic […]

Karuna Receives $8 Million Wellcome Trust Award to Advance First-in-Class Phase 2 Clinical Program in Schizophrenia

June 19, 2018

BOSTON–(BUSINESS WIRE)–Karuna Pharmaceuticals, an affiliate of PureTech Health plc (LSE: PRTC), focused on targeting muscarinic receptors for the treatment of disorders marked by psychosis and cognitive symptoms, today announced that it has been awarded approximately $8 million by the Wellcome Trust. The funding will be used to further advance clinical development of Karuna’s lead program, […]

U.S. Patent Office Grants First Charpentier/Doudna Patent Covering CRISPR/Cas9 Gene Editing

June 19, 2018

DUBLIN–(BUSINESS WIRE)–ERS Genomics announced today that the U.S. Patent and Trademark Office (USPTO) has granted Dr. Emmanuelle Charpentier, ERS Genomics’ co-founder, together with the University of California and University of Vienna, their first U.S. patent with claims covering the use of CRISPR/Cas9 technology for gene editing. The patent covers the use of an optimized guide […]

NantKwest Names Sonja Nelson Chief Financial Officer

June 19, 2018

CULVER CITY, Calif.–(BUSINESS WIRE)–NantKwest, Inc. (Nasdaq: NK) today announced the elevation of Sonja Nelson, chief accounting officer for the company, to the role of Chief Financial Officer (CFO). “I’m excited to have her elevated to this leadership role and look forward to working closely with her.” Tweet this Nelson, who first joined NantKwest in 2015, […]

Decibel Therapeutics Closes $55 Million Series C Financing

June 19, 2018

BOSTON–(BUSINESS WIRE)–Decibel Therapeutics, a company dedicated to the discovery and development of breakthrough medicines to treat hearing loss and hearing-related disorders, today announced that it has raised $55M in a Series C financing. All existing investors, including Third Rock Ventures, GV, SR One, and Regeneron Pharmaceuticals, participated in the round, and were joined by new […]

BioStem Technologies Inc. Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients

June 19, 2018

Pompano Beach, FL, June 18, 2018 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine, has completed its facility inspection for its repackaging subsidiary, Qualified Pharma Ingredients Inc, and has been issued a DEA registration […]

Biohaven And Royalty Pharma Announce Royalty Funding And Stock Purchase Agreements Totaling $150 Million

June 19, 2018

NEW HAVEN, Conn. and NEW YORK, June 18, 2018 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven” or the “Company”) and Royalty Pharma announced today that Biohaven has sold tiered, sales-based participation rights on future global net sales of products containing rimegepant (BHV-3000) or BHV-3500 and certain derivative compounds thereof to Royalty Pharma […]

Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer

June 19, 2018

Paris – June 19, 2018 – Sanofi has appointed Jean-Baptiste Chasseloup de Chatillon as Executive Vice President, Chief Financial Officer (CFO) and Member of the Executive Committee, effective October 1st 2018. He will join Sanofi September 1st to ensure a smooth transition with Jérôme Contamine who will retire on September 30th, after more than 9 […]

Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation

June 19, 2018

WOBURN, Mass., June 19, 2018 (GLOBE NEWSWIRE) — Aphios Corporation today announced that it and the LSU Health Shreveport Department of Molecular & Cellular Physiology have been granted United States Patent No. 9,994,585 entitled “Transplantation Therapies,” for the use of the marine pharmaceutical ‘Bryostatin-1’ as an additive to organ transport and storage solutions. ‘Bryostatin-1’ as […]

7 Hills Pharma Launches With $2 Million SBIR Grant in Addition to $4 Million in Seed Capital to Pursue Novel Cancer Therapeutics to Promote a Productive Immune Response and Overcome Drug Resistance

June 19, 2018

HOUSTON, June 19, 2018 (GLOBE NEWSWIRE) — 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, announced today that it has been awarded a $2 million Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) entitled “Development of a small molecule activator of integrin […]

CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Announce Grant of U.S. Patent for CRISPR/Cas9 Genome Editing

June 19, 2018

ZUG, Switzerland and CAMBRIDGE, Mass. and BERKELEY, Calif., June 19, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), Intellia Therapeutics, Inc. (NASDAQ:NTLA), and Caribou Biosciences, Inc., announced that The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier, Ph.D. (collectively, “UC”), co-owners of foundational intellectual property relating to CRISPR/Cas9 genome editing technology, […]

Bill Major Joins Greater Than One as Director of Operational Excellence

June 18, 2018

(New York, NY) June 11, 2018 – Greater Than One (GTO) announced today that William T. Major has joined the agency’s senior leadership team as Director of Operational Excellence. As leader of project management and creative services at GTO, Bill will spearhead process optimization and system integration across all agency of record (AOR) work, which […]

Theranos Announces Management Transition

June 18, 2018

NEWARK, Calif., June 15, 2018 /PRNewswire/ — The Board of Directors of Theranos, Inc., announced today that Elizabeth Holmes has stepped down as Chief Executive Officer and David Taylor, the Company’s General Counsel, has been appointed Chief Executive Officer and General Counsel. Ms. Holmes remains with the Company as Founder and Chair of the Board. […]

Indivior Is Granted Temporary Restraining Order

June 18, 2018

SLOUGH, England, June 15, 2018 /PRNewswire/ — Indivior PLC (LON: INDV) (“Indivior” or the “Company”) today announced that the U.S. District Court for the District of New Jersey has granted Indivior a temporary restraining order (TRO) that compels Dr. Reddy’s (DRL) to immediately cease its launch activities related to SUBOXONE® Film. This TRO will remain […]

Dr. Reddy’s Laboratories defends its right to launch Buprenorphine and Naloxone Sublingual Film in the U.S. Market

June 18, 2018

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that following the launch of its generic Buprenorphine and Naloxone Sublingual Film in the U.S. Market, the U.S. District Court for the District of New Jersey has received and reviewed an emergency application from the plaintiffs in the […]

Translate Bio Launches Proposed Initial Public Offering

June 18, 2018

LEXINGTON, Mass.–(BUSINESS WIRE)–Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced that it has launched an initial public offering of 7,700,000 shares of its common stock. In addition, Translate Bio expects to grant the underwriters a […]

Aerie Pharmaceuticals Announces Appointment of William Coppola as Intellectual Property Counsel

June 18, 2018

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of William Coppola as Intellectual Property Counsel, reporting to John LaRocca, Aerie’s General Counsel. Mr. Coppola will […]

Safe Chain Solutions Opens Utah Location

June 18, 2018

Latest distribution center will provide faster medication deliveries for clients Cambridge, Maryland, June 14, 2018 – Safe Chain Solutions, a Benchworks company, is pleased to announce the company is opening its third distribution center, located in St. George, Utah, to better serve clients. Starting in July 2018, the new distribution center will allow Safe Chain […]

Medicen Paris Region appoints Stéphane Roques as CEO

June 18, 2018

The new Medicen board of directors aims to position the Paris region as a world leading health cluster Paris, June 14, 2018 – Medicen Paris Region, Europe’s leading health cluster, today announces the appointment of Stéphane Roques as CEO with approval from the board of directors. He will be in charge of implementing the cluster’s […]

Record growth at Sterling Pharma Solutions

June 18, 2018

A UK-based contract development and manufacturing organisation (CDMO) has more than doubled its sales since its formation in 2016 as demand for its hazardous chemistry capabilities and active pharmaceutical ingredient (API) services grows. Sterling Pharma Solutions, which launched as an independent CDMO following a management buyout (MBO) of the Shasun Pharma Solutions Dudley site in […]

Clinical Epidemiologist, Mathematician, Open Science & Blockchain Enthusiast Dr. Mehdi Benchoufi Joins Saama Advisory Board

June 18, 2018

CAMPBELL, CA — (June 18, 2018) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors(BOA). Dr. Benchoufi focuses on interfaces between clinical research and open technologies, with a […]

Eloxx Appoints Global Pharmaceutical Leader, Neil Belloff, Executive Vice President, General Counsel and Corporate Secretary

June 18, 2018

WALTHAM, Mass., June 18, 2018 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq:ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that it has appointed Neil Belloff, Executive Vice President, General […]

FEEDBACK